Difficulty: Medium
Average Score: 63%
Testbank
A patient on the oncology unit is receiving carmustine, a chemotherapy agent, and the nurse is aware that a significant side effect of this medication is thrombocytopenia. Which symptom should the nurse assess for in patients at risk for thrombocytopenia?
Correct answer
C
Rationale
C: Epistaxis (nose bleed)
Patients with thrombocytopenia, a common side effect of carmustine, are at increased risk for bleeding due to low platelet counts. Epistaxis is a direct manifestation of this bleeding risk and should be closely monitored in these patients.
A: Interrupted sleep pattern
While interrupted sleep can occur in oncology patients due to various reasons, it is not a specific symptom associated with thrombocytopenia and does not directly relate to bleeding risks.
B: Hot flashes
Hot flashes may occur in some cancer patients as a result of hormonal changes or treatment effects, but they are not indicative of thrombocytopenia or its complications.
D: Increased weight
Weight gain is not a symptom associated with thrombocytopenia and does not relate to the risk of bleeding; rather, it may indicate fluid retention or other unrelated issues.
Patients with thrombocytopenia, a common side effect of carmustine, are at increased risk for bleeding due to low platelet counts. Epistaxis is a direct manifestation of this bleeding risk and should be closely monitored in these patients.
A: Interrupted sleep pattern
While interrupted sleep can occur in oncology patients due to various reasons, it is not a specific symptom associated with thrombocytopenia and does not directly relate to bleeding risks.
B: Hot flashes
Hot flashes may occur in some cancer patients as a result of hormonal changes or treatment effects, but they are not indicative of thrombocytopenia or its complications.
D: Increased weight
Weight gain is not a symptom associated with thrombocytopenia and does not relate to the risk of bleeding; rather, it may indicate fluid retention or other unrelated issues.